MK0507A

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK0507A, covering 2009-05-29 to 2009-05-29. Get the full timeline:

Most recent: Clinical Trial Update: MK0507A Clinical Study in Patients With Glaucoma and Ocular Hypertension (0507A-149)(COMPLETED) [Phase 3]